APOA1 and obesity disorder: The fact that the prevalence of serum anti-apoA-1 IgG positivity was raised in obese subjects to the same extend than what has been retrieved in other high cardiovascular risk settings [18–21], lend modest weight to this hypothesis and further links autoimmunity, cardiovascular diseases, and obesity.